Ronawk
Amy Manning-Bog is an accomplished scientific professional with extensive experience in biotechnology and pharmaceutical development. Currently serving as Chief Scientific Officer at Ronawk and Founder of Stealth Mode Biotech since late 2024, Manning-Bog previously held key leadership positions including Chief Innovation Officer at MRIGlobal and Vice President roles at Atreca, Inc. spanning various aspects of drug discovery and translational sciences. Early career experiences include significant roles at Sangamo BioSciences, SRI International, and The Parkinson's Institute, as well as academic positions as Adjunct Faculty at UC Santa Cruz and The Parkinson's Institute. Manning-Bog earned an Interdisciplinary PhD in Biochemistry and Molecular Biology from the University of Missouri-Kansas City and a Bachelor of Science in Biology from Missouri State University.
This person is not in any teams
This person is not in any offices
Ronawk
Ronawk’s Bio Block Universe is the first expandable Bio Platform from which other applications, processes, and technologies are developed. Ronawk’s Bio Block Universe accelerates time to result by eliminating the need for sub-culture in cell production which subsequently decreases contamination risks and increases cell yield. Ronawk’s Bio Block Universe transforms what was once tedious to effortless by simplifying cell culture workflows through the reduction of labor, materials, and space. Ronawk’s Bio Block Universe increases biological opportunities by recapitulating the native cell environment to maintain cell viability, key characteristics, and secretion of therapeutic biologics.